NRCM
ALT icon

Northern Right Capital Management’s Altimmune ALT Stock Holding History

Northern Right Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,427
Closed -$4.32M – 18
2016
Q4 		$4.32M Buy
4,427
+1,188
+37% +$1.06M 4.41% 6
2016
Q3 		$2.82M Buy
3,239
+1,706
+111% +$1.34M 6.72% 7
2016
Q2 		$1.12M Buy
+1,533
New +$1.05M 1.55% 13

Other funds holding ALT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FQ
First Quadrant Glendale, California $18M AUM 24.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Right Capital Management's ALT Position: Q1 2017 in Review

Northern Right Capital Management sold out of Altimmune (ALT) in Q1 2017, closing a stake of 4,427 shares — an estimated $4.32M sold.

Northern Right Capital Management first reported a position in ALT in Q2 2016 and held it in 3 quarters. The position peaked at $4.32M in Q4 2016. 71 funds tracked by Wall St. Rank hold ALT as of Q1 2017.

  • Northern Right Capital Management reported no remaining Altimmune position as of Q1 2017 after selling out during the quarter.
  • Northern Right Capital Management sold 4,427 Altimmune shares in Q1 2017, an estimated $4.32M.
  • Northern Right Capital Management first reported a position in Altimmune in Q2 2016 and held it in 3 quarters.
  • Northern Right Capital Management's Altimmune position peaked at $4.32M in Q4 2016.
  • 71 funds tracked by Wall St. Rank held Altimmune as of Q1 2017.

Based on Northern Right Capital Management's 13F filing for Q1 2017, filed 15 May 2017.